Q96RT1 (LAP2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 119.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Protein LAP2 Alternative name(s): Densin-180-like protein Erbb2-interacting protein Short name=Erbin | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1412 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Acts as an adapter for the receptor ERBB2, in epithelia. By binding the unphosphorylated 'Tyr-1248' of receptor ERBB2, it may contribute to stabilize this unphosphorylated state. Ref.1 |
| Subunit structure | Interacts with ERBB2, BPAG1 and ITGB4. May favor the localization of ERBB2, by restricting its presence to the basolateral membrane of epithelial cells. Also found to interact with ARVCF and delta catenin. Interacts (via C-terminus) with DST Isoform 3 (via N-terminus). Ref.1 Ref.2 Ref.8 |
| Subcellular location | Cell junction › hemidesmosome. Nucleus membrane By similarity. Note: Found in hemidesmosomes, which are cell-substrate adhesion complexes in stratified epithelia. In transfected cells, either diffusely distributed over the cytoplasm or concentrated at the basolateral membrane. Colocalizes with the adrenergic receptors, ADREN1A and ADREN1B, at the nuclear membrane of cardiac myocytes By similarity. Ref.1 Ref.2 |
| Tissue specificity | Highly expressed in brain, heart, kidney, muscle and stomach, followed by liver, spleen and intestine. Ref.1 |
| Sequence similarities | Belongs to the LAP (LRR and PDZ) protein family. Contains 17 LRR (leucine-rich) repeats. Contains 1 PDZ (DHR) domain. |
| Sequence caution | The sequence AAH50692.1 differs from that shown. Reason: Contaminating sequence. Potential poly-A sequence. The sequence BAA91538.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. |
Ontologies
Alternative products
| This entry describes 8 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q96RT1-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q96RT1-2) The sequence of this isoform differs from the canonical sequence as follows: 1212-1252: Missing. | ||||||
| Isoform 3 (identifier: Q96RT1-3) The sequence of this isoform differs from the canonical sequence as follows: 1212-1252: Missing. 1268-1278: Missing. | ||||||
| Isoform 4 (identifier: Q96RT1-4) The sequence of this isoform differs from the canonical sequence as follows: 1212-1252: Missing. 1353-1377: Missing. | ||||||
| Isoform 5 (identifier: Q96RT1-5) The sequence of this isoform differs from the canonical sequence as follows: 1212-1252: Missing. 1253-1267: Missing. | ||||||
| Isoform 6 (identifier: Q96RT1-6) The sequence of this isoform differs from the canonical sequence as follows: 1212-1252: Missing. 1322-1352: Missing. | ||||||
| Isoform 7 (identifier: Q96RT1-7) The sequence of this isoform differs from the canonical sequence as follows: 1212-1252: Missing. 1253-1267: Missing. 1268-1278: Missing. 1279-1321: Missing. | ||||||
| Isoform 8 (identifier: Q96RT1-8) The sequence of this isoform differs from the canonical sequence as follows: 1212-1252: KHPQTSSSGD...KDVPPDSLMK → SMLSRSFNSN...RRGSGGHIFR | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1412 | 1412 | Protein LAP2 | PRO_0000188301 | ||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||
| Repeat | 23 – 44 | 22 | LRR 1 | |||||||||||||||||||||||||
| Repeat | 47 – 68 | 22 | LRR 2 | |||||||||||||||||||||||||
| Repeat | 70 – 91 | 22 | LRR 3 | |||||||||||||||||||||||||
| Repeat | 93 – 114 | 22 | LRR 4 | |||||||||||||||||||||||||
| Repeat | 116 – 137 | 22 | LRR 5 | |||||||||||||||||||||||||
| Repeat | 139 – 161 | 23 | LRR 6 | |||||||||||||||||||||||||
| Repeat | 162 – 183 | 22 | LRR 7 | |||||||||||||||||||||||||
| Repeat | 185 – 206 | 22 | LRR 8 | |||||||||||||||||||||||||
| Repeat | 208 – 229 | 22 | LRR 9 | |||||||||||||||||||||||||
| Repeat | 231 – 252 | 22 | LRR 10 | |||||||||||||||||||||||||
| Repeat | 254 – 275 | 22 | LRR 11 | |||||||||||||||||||||||||
| Repeat | 277 – 298 | 22 | LRR 12 | |||||||||||||||||||||||||
| Repeat | 300 – 321 | 22 | LRR 13 | |||||||||||||||||||||||||
| Repeat | 323 – 344 | 22 | LRR 14 | |||||||||||||||||||||||||
| Repeat | 346 – 367 | 22 | LRR 15 | |||||||||||||||||||||||||
| Repeat | 369 – 391 | 23 | LRR 16 | |||||||||||||||||||||||||
| Repeat | 392 – 413 | 22 | LRR 17 | |||||||||||||||||||||||||
| Domain | 1321 – 1410 | 90 | PDZ | |||||||||||||||||||||||||
| Compositional bias | 930 – 934 | 5 | Poly-Ser | |||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||
| Modified residue | 440 | 1 | Phosphoserine Ref.11 | |||||||||||||||||||||||||
| Modified residue | 569 | 1 | Phosphoserine Ref.13 Ref.15 | |||||||||||||||||||||||||
| Modified residue | 598 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||
| Modified residue | 602 | 1 | Phosphoserine Ref.15 | |||||||||||||||||||||||||
| Modified residue | 603 | 1 | Phosphoserine Ref.15 | |||||||||||||||||||||||||
| Modified residue | 715 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||
| Modified residue | 853 | 1 | Phosphothreonine By similarity | |||||||||||||||||||||||||
| Modified residue | 857 | 1 | Phosphoserine Ref.13 | |||||||||||||||||||||||||
| Modified residue | 872 | 1 | Phosphoserine Ref.14 | |||||||||||||||||||||||||
| Modified residue | 917 | 1 | Phosphothreonine Ref.13 Ref.14 | |||||||||||||||||||||||||
| Modified residue | 920 | 1 | Phosphotyrosine Ref.9 | |||||||||||||||||||||||||
| Modified residue | 931 | 1 | Phosphoserine Ref.14 | |||||||||||||||||||||||||
| Modified residue | 972 | 1 | Phosphotyrosine Ref.10 | |||||||||||||||||||||||||
| Modified residue | 1104 | 1 | Phosphotyrosine By similarity | |||||||||||||||||||||||||
| Modified residue | 1158 | 1 | Phosphoserine Ref.14 | |||||||||||||||||||||||||
| Modified residue | 1179 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||
| Modified residue | 1286 | 1 | Phosphoserine Ref.13 | |||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||
| Alternative sequence | 1212 – 1252 | 41 | Missing in isoform 2, isoform 3, isoform 4, isoform 5, isoform 6 and isoform 7. | VSP_010802 | ||||||||||||||||||||||||
| Alternative sequence | 1212 – 1252 | 41 | KHPQT…DSLMK → SMLSRSFNSNFTTVSSFHCG SSRDLHGSQGSLALSVADRR GSGGHIFR in isoform 8. | VSP_044536 | ||||||||||||||||||||||||
| Alternative sequence | 1253 – 1267 | 15 | Missing in isoform 5 and isoform 7. | VSP_010803 | ||||||||||||||||||||||||
| Alternative sequence | 1268 – 1278 | 11 | Missing in isoform 3 and isoform 7. | VSP_010804 | ||||||||||||||||||||||||
| Alternative sequence | 1279 – 1321 | 43 | Missing in isoform 7. | VSP_010805 | ||||||||||||||||||||||||
| Alternative sequence | 1322 – 1352 | 31 | Missing in isoform 6. | VSP_010806 | ||||||||||||||||||||||||
| Alternative sequence | 1353 – 1377 | 25 | Missing in isoform 4. | VSP_010807 | ||||||||||||||||||||||||
| Natural variant | 274 | 1 | S → L. Ref.7 Corresponds to variant rs3213837 [ dbSNP | Ensembl ]. | VAR_019346 | ||||||||||||||||||||||||
| Natural variant | 313 | 1 | A → V. Ref.7 Corresponds to variant rs191137999 [ dbSNP | Ensembl ]. | VAR_068905 | ||||||||||||||||||||||||
| Natural variant | 746 | 1 | K → E. Corresponds to variant rs16894812 [ dbSNP | Ensembl ]. | VAR_028304 | ||||||||||||||||||||||||
| Natural variant | 914 | 1 | K → R. Corresponds to variant rs34521887 [ dbSNP | Ensembl ]. | VAR_046673 | ||||||||||||||||||||||||
| Natural variant | 1089 | 1 | G → V. Corresponds to variant rs35601230 [ dbSNP | Ensembl ]. | VAR_046674 | ||||||||||||||||||||||||
| Natural variant | 1112 | 1 | S → L. Corresponds to variant rs3805466 [ dbSNP | Ensembl ]. | VAR_019347 | ||||||||||||||||||||||||
| Natural variant | 1207 | 1 | K → E. Ref.2 | VAR_019348 | ||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||
| Sequence conflict | 271 | 1 | T → P in AAI15013. Ref.7 | |||||||||||||||||||||||||
| Sequence conflict | 531 – 534 | 4 | Missing in AAH50692. Ref.7 | |||||||||||||||||||||||||
| Sequence conflict | 547 | 1 | D → G in AAI15013. Ref.7 | |||||||||||||||||||||||||
| Sequence conflict | 805 | 1 | E → G in BAA91538. Ref.5 | |||||||||||||||||||||||||
| Sequence conflict | 813 | 1 | Y → C in AAK69431. Ref.2 | |||||||||||||||||||||||||
| Sequence conflict | 848 | 1 | G → C in BAG65463. Ref.5 | |||||||||||||||||||||||||
| Sequence conflict | 1047 | 1 | R → S in BAG65463. Ref.5 | |||||||||||||||||||||||||
| Sequence conflict | 1205 | 1 | E → G in AAI15013. Ref.7 | |||||||||||||||||||||||||
| Sequence conflict | 1267 | 1 | Q → P in AAI15013. Ref.7 | |||||||||||||||||||||||||
| Sequence conflict | 1328 | 1 | K → R in AAI15013. Ref.7 | |||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||
| Beta strand | 1318 – 1327 | 10 | ||||||||||||||||||||||||||
| Beta strand | 1329 – 1331 | 3 | ||||||||||||||||||||||||||
| Beta strand | 1333 – 1338 | 6 | ||||||||||||||||||||||||||
| Turn | 1339 – 1342 | 4 | ||||||||||||||||||||||||||
| Beta strand | 1346 – 1348 | 3 | ||||||||||||||||||||||||||
| Beta strand | 1353 – 1359 | 7 | ||||||||||||||||||||||||||
| Turn | 1364 – 1368 | 5 | ||||||||||||||||||||||||||
| Beta strand | 1374 – 1378 | 5 | ||||||||||||||||||||||||||
| Helix | 1388 – 1397 | 10 | ||||||||||||||||||||||||||
| Beta strand | 1400 – 1410 | 11 | ||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor." Borg J.-P., Marchetto S., Le Bivic A., Ollendorff V., Jaulin-Bastard F., Saito H., Fournier E., Adelaide J., Margolis B., Birnbaum D. Nat. Cell Biol. 2:407-414(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), INTERACTION WITH ERBB2, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, FUNCTION. Tissue: B-cell. |
| [2] | "The hemidesmosomal protein bullous pemphigoid antigen 1 and the integrin beta 4 subunit bind to ERBIN. Molecular cloning of multiple alternative splice variants of ERBIN and analysis of their tissue expression." Favre B., Fontao L., Koster J., Shafaatian R., Jaunin F., Saurat J.-H., Sonnenberg A., Borradori L. J. Biol. Chem. 276:32427-32436(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5; 6 AND 7), INTERACTION WITH BPAG1; DST AND ITGB4, SUBCELLULAR LOCATION, VARIANT GLU-1207. |
| [3] | "Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O. DNA Res. 6:337-345(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Brain. |
| [4] | "Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones." Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T. DNA Res. 9:99-106(2002) [PubMed] [Europe PMC] [Abstract] Cited for: SEQUENCE REVISION. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 601-1206 (ISOFORM 1). Tissue: Teratocarcinoma and Uterus. |
| [6] | "The DNA sequence and comparative analysis of human chromosome 5." Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M., She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S. Rubin E.M.Nature 431:268-274(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 8), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-634 (ISOFORM 1), VARIANTS LEU-274 AND VAL-313. Tissue: Cerebellum and Skin. |
| [8] | "The Erbin PDZ domain binds with high affinity and specificity to the carboxyl termini of delta-catenin and ARVCF." Laura R.P., Witt A.S., Held H.A., Gerstner R., Deshayes K., Koehler M.F.T., Kosik K.S., Sidhu S.S., Lasky L.A. J. Biol. Chem. 277:12906-12914(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH DELTA CATENIN AND ARVCF. |
| [9] | "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry." Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M., Peters E.C. Anal. Chem. 76:2763-2772(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-920, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [10] | "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells." Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.-M., Polakiewicz R.D., Comb M.J. Nat. Biotechnol. 23:94-101(2005) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-972, MASS SPECTROMETRY. |
| [11] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-440, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Platelet. |
| [13] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569; SER-857; THR-917 AND SER-1286, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-872; THR-917; SER-931 AND SER-1158, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [15] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569; SER-602 AND SER-603, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [17] | "Novel mode of ligand recognition by the Erbin PDZ domain." Birrane G., Chung J., Ladias J.A. J. Biol. Chem. 278:1399-1402(2003) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.25 ANGSTROMS) OF 1321-1412 IN COMPLEX WITH ERBB2 C-TERMINUS. |
| [18] | "Origins of PDZ domain ligand specificity. Structure determination and mutagenesis of the Erbin PDZ domain." Skelton N.J., Koehler M.F.T., Zobel K., Wong W.L., Yeh S., Pisabarro M.T., Yin J.P., Lasky L.A., Sidhu S.S. J. Biol. Chem. 278:7645-7654(2003) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 1314-1412 IN COMPLEX WITH PHAGE-DERIVED PEPTIDE. |
| [19] | "Comparative structural analysis of the erbin PDZ domain and the first PDZ domain of ZO-1. Insights into determinants of PDZ domain specificity." Appleton B.A., Zhang Y., Wu P., Yin J.P., Hunziker W., Skelton N.J., Sidhu S.S., Wiesmann C. J. Biol. Chem. 281:22312-22320(2006) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.0 ANGSTROMS) OF 1314-1412. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF263744 mRNA. Translation: AAF77048.1. AF276423 mRNA. Translation: AAK69431.1. AB033051 mRNA. Translation: BAA86539.2. AK001180 mRNA. Translation: BAA91538.1. Different initiation. AK304693 mRNA. Translation: BAG65463.1. AC010359 Genomic DNA. No translation available. AC025442 Genomic DNA. No translation available. BC050692 mRNA. Translation: AAH50692.1. Sequence problems. BC115012 mRNA. Translation: AAI15013.1. BC126464 mRNA. Translation: AAI26465.1. BC144075 mRNA. Translation: AAI44076.1. | ||||||||||||||||||||||||||||||||||||||||||
| IPI | IPI00438286. IPI00438287. IPI00438288. IPI00438289. IPI00438290. IPI00438291. IPI00438292. | ||||||||||||||||||||||||||||||||||||||||||
| RefSeq | NP_001006600.1. NM_001006600.2. NP_001240626.1. NM_001253697.1. NP_001240627.1. NM_001253698.1. NP_001240628.1. NM_001253699.1. NP_001240630.1. NM_001253701.1. NP_061165.1. NM_018695.3. | ||||||||||||||||||||||||||||||||||||||||||
| UniGene | Hs.597241. Hs.731734. Hs.740465. | ||||||||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||||||||||||||
| ProteinModelPortal | Q96RT1. | ||||||||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||||||||||||||
| IntAct | Q96RT1. 9 interactions. | ||||||||||||||||||||||||||||||||||||||||||
| MINT | MINT-199447. | ||||||||||||||||||||||||||||||||||||||||||
| STRING | 9606.ENSP00000370330. | ||||||||||||||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||||||||||||||
| PhosphoSite | Q96RT1. | ||||||||||||||||||||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||||||||||||||||||||
| DMDM | 116242614. | ||||||||||||||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||||||||||||||
| PaxDb | Q96RT1. | ||||||||||||||||||||||||||||||||||||||||||
| PRIDE | Q96RT1. | ||||||||||||||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||||||||||||||
| Ensembl | ENST00000284037; ENSP00000284037; ENSG00000112851. ENST00000380935; ENSP00000370322; ENSG00000112851. ENST00000380936; ENSP00000370323; ENSG00000112851. ENST00000380938; ENSP00000370325; ENSG00000112851. ENST00000380939; ENSP00000370326; ENSG00000112851. ENST00000380943; ENSP00000370330; ENSG00000112851. ENST00000506030; ENSP00000426632; ENSG00000112851. ENST00000508515; ENSP00000422015; ENSG00000112851. | ||||||||||||||||||||||||||||||||||||||||||
| GeneID | 55914. | ||||||||||||||||||||||||||||||||||||||||||
| KEGG | hsa:55914. | ||||||||||||||||||||||||||||||||||||||||||
| UCSC | uc003jui.2. human. uc003juj.2. human. uc003juk.2. human. uc011cqy.2. human. | ||||||||||||||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||||||||||||||
| CTD | 55914. | ||||||||||||||||||||||||||||||||||||||||||
| GeneCards | GC05P065258. | ||||||||||||||||||||||||||||||||||||||||||
| HGNC | HGNC:15842. ERBB2IP. | ||||||||||||||||||||||||||||||||||||||||||
| HPA | HPA048606. | ||||||||||||||||||||||||||||||||||||||||||
| MIM | 606944. gene. | ||||||||||||||||||||||||||||||||||||||||||
| neXtProt | NX_Q96RT1. | ||||||||||||||||||||||||||||||||||||||||||
| PharmGKB | PA27845. | ||||||||||||||||||||||||||||||||||||||||||
| HUGE | Search... | ||||||||||||||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||||||||||||||
| eggNOG | COG4886. | ||||||||||||||||||||||||||||||||||||||||||
| HOGENOM | HOG000060229. | ||||||||||||||||||||||||||||||||||||||||||
| HOVERGEN | HBG052305. | ||||||||||||||||||||||||||||||||||||||||||
| InParanoid | Q96RT1. | ||||||||||||||||||||||||||||||||||||||||||
| KO | K12796. | ||||||||||||||||||||||||||||||||||||||||||
| OMA | HNNVRAN. | ||||||||||||||||||||||||||||||||||||||||||
| OrthoDB | EOG41JZBG. | ||||||||||||||||||||||||||||||||||||||||||
| PhylomeDB | Q96RT1. | ||||||||||||||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||||||||||||||
| Reactome | REACT_111102. Signal Transduction. | ||||||||||||||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||||||||||||||
| ArrayExpress | Q96RT1. | ||||||||||||||||||||||||||||||||||||||||||
| Bgee | Q96RT1. | ||||||||||||||||||||||||||||||||||||||||||
| CleanEx | HS_ERBB2IP. | ||||||||||||||||||||||||||||||||||||||||||
| Genevestigator | Q96RT1. | ||||||||||||||||||||||||||||||||||||||||||
| GermOnline | ENSG00000112851. Homo sapiens. | ||||||||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||||||||
| InterPro | IPR001611. Leu-rich_rpt. IPR025875. Leu-rich_rpt_4. IPR001478. PDZ. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||
| Pfam | PF12799. LRR_4. 2 hits. PF00595. PDZ. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||
| SMART | SM00228. PDZ. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||
| SUPFAM | SSF50156. PDZ. 1 hit. | ||||||||||||||||||||||||||||||||||||||||||
| PROSITE | PS51450. LRR. 15 hits. PS50106. PDZ. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||||||||||||||
| ChiTaRS | ERBB2IP. human. | ||||||||||||||||||||||||||||||||||||||||||
| EvolutionaryTrace | Q96RT1. | ||||||||||||||||||||||||||||||||||||||||||
| GenomeRNAi | 55914. | ||||||||||||||||||||||||||||||||||||||||||
| NextBio | 61305. | ||||||||||||||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | LAP2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q96RT1 Secondary accession number(s): A0AVR1 Q9ULJ5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
